![Jean-Michel Gries](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Michel Gries
President chez
Hengenix Biotech, Inc.
Profil
Jean-Michel Gries is currently the President & Chief Operating Officer at Aitia, Inc. and also the President at Hengenix Biotech, Inc. He previously worked as a Director at Immunetrics, Inc. Gries completed his undergraduate and doctorate degrees from Université de Paris 5 René Descartes and earned an MBA from The Wharton School of the University of Pennsylvania.
Postes actifs de Jean-Michel Gries
| Sociétés | Poste | Début |
|---|---|---|
Hengenix Biotech, Inc.
 Hengenix Biotech, Inc. Aerospace & DefenseElectronic Technology Hengenix Biotech, Inc., operating as Hengennix, is a biotech-focused platform that provides news, breakthroughs, and insights in the biotechnology industry. The private company is based in Fremont. The American company features articles on company developments, the application of AI, translation, and innovations impacting medicine and human health. It offers multilingual content and covers topics such as advancements beyond medicine and the ongoing race for biotech progress. Hengennix is also associated with Linkflow, a team that improves business search engine rankings through personalized link-building strategies, content creation, and industry networking. The platform emphasizes intellectual property protection with a detailed DMCA policy for handling copyright infringement related to its content and services. The CEO of the company is Wen Jie Zhang. | President | - |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | President | 19/09/2023 |
Anciens postes connus de Jean-Michel Gries
| Sociétés | Poste | Fin |
|---|---|---|
Immunetrics, Inc.
 Immunetrics, Inc. BiotechnologyHealth Technology Operates as a bio-simulation company | Directeur/Membre du Conseil | - |
Formation de Jean-Michel Gries
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Immunetrics, Inc.
Immunetrics, Inc. BiotechnologyHealth Technology Operates as a bio-simulation company | Health Technology |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hengenix Biotech, Inc.
Hengenix Biotech, Inc. Aerospace & DefenseElectronic Technology Hengenix Biotech, Inc., operating as Hengennix, is a biotech-focused platform that provides news, breakthroughs, and insights in the biotechnology industry. The private company is based in Fremont. The American company features articles on company developments, the application of AI, translation, and innovations impacting medicine and human health. It offers multilingual content and covers topics such as advancements beyond medicine and the ongoing race for biotech progress. Hengennix is also associated with Linkflow, a team that improves business search engine rankings through personalized link-building strategies, content creation, and industry networking. The platform emphasizes intellectual property protection with a detailed DMCA policy for handling copyright infringement related to its content and services. The CEO of the company is Wen Jie Zhang. | Electronic Technology |
